Studies have shown that HTRA1 can promote transforming growth factor (TGF)β1 signaling by cleaving latent TGFβ-binding protein, which directly contributes to the occurrence of cerebral small vessel disease and scar activation [38, 73]. Here, HTRA1 is linked to cerebral small vessel disease.